- $83.95bn
- $102.18bn
- £31.38bn
- 70
- 69
- 84
- 87
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK and Alector collaboration in immuno-neurology
AnnouncementREG - GlaxoSmithKline PLC - Elliott Advisors (UK) letter to GSK
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK to deliver step-change in growth & performance
AnnouncementREG - GlaxoSmithKline PLC - ViiV/Halozyme sign exclusive licensing agreement
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - GSK and iTeos announce collaboration for EOS-448
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - BMO UK High Inc Tst BMO UK High Inc-BHIB BMO UK High Inc-BHIU - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - GSK recommend ADR holders reject mini-tender offer
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
Announcement